Thomas McNerney & Partners Overview

  • Investor Type
  • Venture Capital
  • Status
  • Inactive
  • Professionals
  • 2
Professionals
  • Investments
  • 104
  • Portfolio
  • 3
  • Exits
  • 62
Exits

Thomas McNerney & Partners General Information

Description

Thomas McNerney & Partners is a healthcare venture capital firm that invests in life science and medical technology companies at all stages of development. The firm was founded in 2001 and is based in Stamford, Connecticut.

Contact Information

Formerly Known As
Lumina Ventures
Year Founded
2001
Investor Status
Not Making New Investments
Primary Investor Type
Venture Capital
Primary Office
  • One Stamford Plaza
  • 263 Tresser Boulevard, 9th Floor
  • Stamford, CT 06901
  • United States
+1 (203) 000-0000

Thomas McNerney & Partners Investments (104)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Vertiflex 27-Mar-2018 Later Stage VC 000.00 Therapeutic Devices Generating Revenue 00000000 0000
00000 0000000 25-Jul-2016 00000 00000 0000 Surgical Devices Generating Revenue 00000 00000000
000000000 04-Jan-2016 00000 00000 000.00 Therapeutic Devices Generating Revenue 00000000 0000
0000000 0000000 09-Jul-2015 00000 00000 000.00 Monitoring Equipment Generating Revenue/Not Profitable
00000 11-Nov-2014 00000 00000 000.00 Drug Discovery Out of Business 000000 0000 00.0
0000000 13-Oct-2014 00000 00000 00000 Clinics/Outpatient Services Generating Revenue/Not Profitable 0000 000000 00
000000 00000000 00 19-Sep-2014 0000000000 Other Commercial Services Generating Revenue 00000 000000
00 00000000 09-Sep-2014 00000 00000 0000 Publishing Generating Revenue 000000 0000 00.0
Penn Pharmaceutical Services 30-Jul-2014 Buyout/LBO 00000 Pharmaceuticals Generating Revenue 00000 000000
Auspex Pharmaceuticals 20-Dec-2013 Later Stage VC 000.00 Drug Discovery Clinical Trials - Phase 3 000000 0000 00.0
You’re viewing 10 of 104 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Thomas McNerney & Partners Exits (62)

Company Name Exit Date Exit Type Exit Size
Clarus Therapeutics 09-Sep-2021 Reverse Merger 000.00
00000 0000000 01-Dec-2019 000 00 00000000
000000000 11-Jun-2019 000000000000000000 00000
0000-00000 00000 18-Apr-2019 000000000000000000 00000
00000000 000000 04-Jun-2018 0000000000 0000
0000000 05-Apr-2018 000000000 00000000
00000 0000000 23-Mar-2017 000000000000000000
00000 0000000 15-Jun-2016 000000000000000000 00000
PCI Pharma Services 01-Jun-2016 Buyout/LBO 000
The Medicines Company 01-Feb-2016 Merger/Acquisition 00000
You’re viewing 10 of 62 exits. Get the full list »

Thomas McNerney & Partners Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Thomas McNerney & Partners‘s full profile, request access.

Request a free trial

Thomas McNerney & Partners Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Thomas McNerney & Partners Team (26)

Name Title Deals Funds Boards Office
James Thomas Co-Founder & Partner 00 0 0 Stamford, CT
Kristi LaCroix Controller Minneapolis, MN
Alex Zisson Advisor 00 0 0 Stamford, CT
Kathleen Tune Advisor 0 0 0 Minneapolis, MN
You’re viewing 4 of 26 team members. Get the full list »

Thomas McNerney & Partners Co-Investors (5)

Name With Exits Lead Partner Series Industry
Alta Partners 1 0 0 Series chart Industry bar
Endeavour Vision 0 0 0 Series chart Industry bar
H.I.G. BioHealth Partners 0 0 0 Series chart Industry bar
H.I.G. Capital 0 0 0 Series chart Industry bar
New Enterprise Associates 0 0 0 Series chart Industry bar
To view Thomas McNerney & Partners’s complete co-investors history, request access »